Dr. Israel Meir Ackerman, MD

Dr. Ackerman practices at Advanced Eye Care Center in Denton, Texas.

Dr. Ackerman's NPI, 1619402260, was assigned on April 20, 2017. Dr. Ackerman graduated from New York Medical College in 2017. Dr. Ackerman holds Texas license T0403.

Dr. Ackerman's primary practice is Advanced Eye Care Center, at 2210 San Jacinto Blvd Suite 1 Suite 1, Denton, TX 76205-7531. The practice phone is (940) 382-8000.

Dr. Ackerman's primary practice is Advanced Eye Care Center in Denton, Texas. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Ackerman to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ackerman practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ackerman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ackerman is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Ackerman is licensed in Texas.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Ackerman treats.

CMS data shows 128 Medicare services from Dr. Ackerman across 8 procedure codes in 2024, for 51 Medicare patients. Medicare paid $10,222 for them.

CMS counts 51 Medicare patients who saw Dr. Ackerman in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ackerman's median patient age at 72, with 59% women.

In 2024, Dr. Ackerman wrote 103 Medicare Part D claims for 62 patients. 65% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $599 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ackerman for performance year 2024, reported as part of a group. Dr. Ackerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 247 procedures of cataract surgery by Dr. Ackerman, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Ackerman, published from 2017 to 2021. 2021 was the busiest year, with 3. Dr. Ackerman's most frequent co-authors are Enrico Ascher, MD, Nika Finelt, MD and Naomi Goldberg, MD.

CMS Open Payments shows 108 general payments to Dr. Ackerman from 13 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 67% of the total. Bausch & Lomb Americas Inc. paid the most, $1,878.

Dmand AI lists 2 awards for Dr. Ackerman, most recently Texas Rising Stars in 2025.

Dr. Ackerman graduated from New York Medical College in 2017.

Dr. Ackerman is in network with 21 carriers, including Elevance, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.